Growth Drivers

Industry leaders share valuable insights with Shriyal Sethumadhavan on current opportunities, company growth, and the impact of innovative products in the thriving aesthetic medicine market.

In recent years, the aesthetic industry has witnessed extraordinary growth and innovation. Reports indicate that the global aesthetic medicine market is expected to grow to $91.27 billion in 2027 at a CAGR of 9.8 per cent. Evolving beauty standards, heightened awareness, and the emergence of non-invasive aesthetic procedures, coupled with advanced technological developments, have fuelled the demand for aesthetic treatments and products. As the industry adapts to this changing landscape, key players in the industry share valuable insights into current opportunities, their influence on company growth, and more.

“Themarket is morphing into a fusion of beauty and clinical treatments.”

“All indications from industry pundits suggest that the Aesthetic industry is poised to grow significantly in the next few years. Aesthetics has become the new mantra adopted by leading dermatologists, and the market is morphing into a fusion of beauty and clinical treatments, finding a broad-based appeal among end-users.

Having foreseen this emerging global trend a few years ago, Repechage decided to launch new products for both salons and dermatologists. Dermatologists seek genuine and natural products that can be a value-add to their core (clinically oriented) procedures, helping heal and repair the skin while being aesthetically pleasing. The Repechage brand fills this critical space, intersecting salons and dermatologists, by offering high-quality, non-invasive treatments to address all major skin concerns. Most signature treatments are dermatologist-tested and backed by extensive field trials and studies.

One of our several best-sellers, the Repechage Hydra Dew Pure Facial, is designed to restore and renew the skin damaged by UV light and aggressive clinical treatments such as microdermabrasion and chemical peels. It has also proven effective for oncology patients, helping to heal the skin after administering harsh medical treatments like radiation and chemotherapy.

Repêchage® exclusive potent Seaweed Extracts, Organic Cannabis Sativa Seed Oil, Precious Mastic Oil from the Aegean, and Camellia Japonica Seed Oil from Japan have been combined with many other active ingredients to provide deep nourishment, hydration, and soothing for dry, compromised skin. Another popular offering is the Biolight Miracle Facial with Glyco-Sea Glycolic Peel for hyper-pigmentation and uneven, sallow skin tone. The Repechage Glyco-sea Glycolic Peel is an intensive skin treatment that focuses on resurfacing and renewing the skin, revealing a more luminous, youthful complexion while causing less irritation than standard glycolic peels.

The company’s in-house R&D, in consultation with dermatologists and cosmetologists, is constantly working to create new breakthrough products and treatments to help heal and repair the skin.”

“Aestheticmedicine is the fastest-growing branch of healthcare today.”

“With the rising income levels in India and the introduction of new products and procedures, Aesthetic medicine has finally taken off. Social changes taking place in the country have made products and procedures more popular. Nowadays, nobody wants to look old, and even in a professional environment, looking sharp and smart all the time is considered essential. Aesthetic medicine is the fastest-growing branch of healthcare today and represents a Rs 40,000-crore industry. The post-COVID recovery for the industry was quick, proving the strong demand for these treatments. Moreover, we are witnessing doctors from varied backgrounds joining the aesthetic field, which only increases the opportunities. Events organised by magazines like Aesthetic Medicine India provide us with a platform to showcase our products on a large scale.

Numero Uno Pharma was launched during the testing times of COVID, and we observed that our doctors were looking for good-quality products at patient-friendly pricing. To tap into the growing market’s opportunities, we provided a wide range of homecare and procedure products in one place. Our doctors are pleased to find a one-stop shop for the diverse range of products they need. Our product lineup includes an entire range of PRP, rollers, serums, peels, and various home care products.

One of our latest products launched is the ‘U-Fresh Deo-RollOn’, an underarm lightening, moisturising, and antiperspirant deodorant that is free from aluminium, alcohol, and triclosan. It received an overwhelming response during the recently concluded Aesthetic Medicine conference. We plan to introduce more innovative products in the near future.”

“Aakaaris focusing on exosome-based formulations.”

“The Indian medical aesthetic market is on the cusp of a remarkable transformation, and Aakaar stands as a trailblazer in this exciting journey. The field of medical aesthetics has witnessed remarkable growth and innovation in recent years, and the Indian market is no exception. With an increasing emphasis on self-care and personal grooming, the demand for aesthetic treatments and products has surged. In this evolving landscape, Aakaar has emerged as a pioneer, dominating the market for over two decades. Now, as the industry reaches a tipping point, the company is poised to propel this market to unprecedented heights.

With a legacy spanning 24 years, Aakaar has established itself as a trusted leader in the market. The company’s commitment to quality and efficacy has garnered a loyal customer base. Its latest offerings, êtrelume, êtrehair, and SWYADA, are functional aesthetic products with high-quality ingredients and effective concentrations. These products have been meticulously formulated to address a wide range of aesthetic concerns, providing customers with enhanced results and satisfaction.

The company is at the forefront of innovation, continually exploring new avenues to enhance its product range. It is currently focused on developing skincare and haircare formulations based on exosomes. These cutting-edge technologies hold immense potential for rejuvenation and regeneration, offering customers novel and effective solutions for their aesthetic needs.”

“Myolift MD enables practitioners to cater to a wider range of client needs.”

“The remarkable growth of India’s aesthetics industry in recent years has been due to factors such as a prospering middle class, growing beauty consciousness, and technological advancements. This presents us with a golden opportunity to introduce our innovative product, the Myolift MD microcurrent facial device.

The Myolift MD is an advanced non-invasive device that offers a wide range of benefits, including a non-surgical facelift and the reduction of wrinkles. Specifically designed for professional use, the device ensures that it meets the highest standards of quality and efficacy. With its ability to tone, lift, treat acne, and address hyper-pigmentation, Myolift MD offers immediate and impressive results. Moreover, the device presents an excellent opportunity for aesthetic practitioners to expand their service offerings. With eight different noninvasive pre-set programmes and microamps ranging up to 800, our Myolift Microcurrent Facial device complements professional treatments, enabling practitioners to cater to a wider range of client needs.”

“We are India’s first CDSCO-approved company to manufacture regenerative therapy products. ”

“Indian innovators and customers are not new to the aesthetic segment. The country has given the world Ayurveda, one of the oldest treatment modalities with beauty and aesthetic solutions. Continuing the tradition of innovation and adding the benefits of modern science and cutting-edge technology, we now stand at an exciting onset of growth in the aesthetic industry.

The development of non/minimally invasive procedures gives patients lower cost, lower risk, and no or low downtime options, making them extremely popular. Apart from the introduction of innovative procedures, disposable income levels have risen in India, and people are willing to spend beyond basic care. Thus, the personal wellness and aesthetic industry is bound to grow exponentially.

There is a rise in consumer interest in hair, skin, smile, and overall aesthetics. Along with that, India has the potential to provide top-quality products, serviced by experts in fully equipped and top-notch centres. We, at Levram Lifesciences, believe the combination of these two factors makes the aesthetic industry an exciting space to be in and has also driven our growth. Levram Lifesciences is India’s first CDSCOapproved company to manufacture regenerative therapy products such as GFC, PRP, and PRF. Under this wing, we cater to a revolutionary technology that uses a patient’s own blood to accelerate healing and aid in regeneration for a variety of conditions, from treating skin concerns to hair loss.”

“Wehave revolutionised the hair restoration journey for both patients and doctors. ”

“India is a significant market for hair care products and services, with the market anticipated to reach more than Rs 44,800 crore at the end of the forecast period 2027-28, experiencing steady growth of 8 per cent.

Hair loss and hair thinning are common concerns among the Indian population, and this has fuelled the growth of the hair restoration market. However, hair loss is a complex condition with multiple etiologies. Therefore, identifying and addressing the root cause of hair loss by a dermatologist or trichologist is crucial for an effective treatment.

The traditional treatments/OTC products available in the market have their own limitations, such as no clinical data, variable results, discomfort, potential side effects, and lack of standardisation, making them time-consuming procedures.

Scientifically validated QR678 Neo fills this gap and addresses the root causes of hair loss with its unique formulation of six specific hair growth factors. It has undergone rigorous testing and research for over 16 years to demonstrate its effectiveness. It also provides a higher level of credibility, efficacy, and safety. It is US-patented, India-patented, and regulatory-approved in more than 10 countries. QR678 Neo is a non-invasive, safe option with negligible side-effects, making it a convenient choice for both patients and doctors as it only requires a quick 10-minute procedure. Today, this is the product of choice in 1,000+ clinics and by doctors. As a company collaborating with doctors and providing training, this is a crucial step in ensuring optimal patient care and successful outcomes. QR678 has revolutionised the hair restoration journey for both patients and doctors alike.”

“We are trailblazers in clinically studied ingredients.”

“We are witnessing the aesthetic industry evolve rapidly, with a growing demand for research-based, clinically studied ingredients and products.

At Direct2Dermatologist, we have been trailblazers in working with clinically studied ingredients and product formulations. We have observed that the end consumers for doctors, i.e., their patients, are becoming more aware of the ingredients used in the products and are demanding transparency to ensure the safety of what they are consuming or applying to their bodies. This is where we step in with our clinically studied ingredients and product formulations, creating high-efficacy, researched products with full transparency and science-backed clinically tested ingredients. This provides a trust factor for the doctors and their patients simultaneously.”

“Ourleadership is defined by unwavering dedication to meeting our customers’ needs.”

“The current landscape is witnessing a high demand for advanced skin and hair care solutions. As the interest in both surgical and non-surgical cosmetic procedures increase, individuals are choosing Renewcell Cosmedica for our exceptional products and treatments. We are well-positioned to capitalise on the multitude of opportunities for growth in this thriving industry.

Our best-selling product, Retipeel.md: Tranex Retipeel, exemplifies our dedication to market revolution. This exceptional offering harmoniously blends carefully chosen ingredients to target diverse skin concerns. The powerful combination of retinol and tranexamic acid in Retipeel.md ensures optimal skin absorption, maximising its efficacy. Additionally, our depigmentation segment includes Melanoceuticals and Skinesse brightening products.

Hair Systems and Hair Peptide are designed for hair growth and regeneration. In addition, we provide three RX products, Eclipse Solaire sunscreen, Vitamin C serum, and Retinol + Peptide night cream, specifically designed for dermatologists and a wider audience. With our current momentum and the opportunities ahead, we are committed to making a significant impact in the field of aesthetic medicine. Our leadership is defined by innovation, effectiveness, and unwavering dedication to meeting our customers’ needs.”